Therapy and clinical trials.

dc.contributor.author	Elmallah, Wael
dc.contributor.author	Krasuski, Richard A
dc.coverage.spatial	England
dc.date.accessioned	2015-12-03T17:40:37Z
dc.date.issued	2011-12
dc.identifier	http://www.ncbi.nlm.nih.gov/pubmed/22101564
dc.identifier	00041433-201112000-00014
dc.identifier.eissn	1473-6535
dc.identifier.uri	https://hdl.handle.net/10161/11019
dc.language	eng
dc.publisher	Ovid Technologies (Wolters Kluwer Health)
dc.relation.ispartof	Curr Opin Lipidol
dc.relation.isversionof	10.1097/MOL.0b013e32834d208d
dc.subject	Cholesterol Ester Transfer Proteins
dc.subject	Coronary Artery Disease
dc.subject	Diabetes Mellitus
dc.subject	Drug Therapy, Combination
dc.subject	Humans
dc.subject	Hydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subject	Hypolipidemic Agents
dc.subject	Niacin
dc.subject	Randomized Controlled Trials as Topic
dc.subject	Sulfhydryl Compounds
dc.title	Therapy and clinical trials.
dc.type	Journal article
duke.contributor.orcid	Krasuski, Richard A\|0000-0003-3150-5215
pubs.author-url	http://www.ncbi.nlm.nih.gov/pubmed/22101564
pubs.begin-page	512
pubs.end-page	513
pubs.issue	6
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Duke
pubs.organisational-group	Medicine
pubs.organisational-group	Medicine, Cardiology
pubs.organisational-group	School of Medicine
pubs.publication-status	Published
pubs.volume	22

Files

Now showing 1 - 1 of 1